Abstract
Welcome to this in-depth exploration of thyroid health. In my years of clinical practice, I have seen countless individuals who, despite being on thyroid medication and having "normal" lab results, continue to suffer from the debilitating symptoms of hypothyroidism. My name is Dr. Alex Jimenez, and with my background in both chiropractic and functional medicine, my goal is to bridge the gap between conventional understanding and the intricate physiological realities of the human body. This educational post delves into a critical, yet often overlooked, aspect of thyroid health: the paramount importance of Free T3 (FT3)—the active, "workhorse" thyroid hormone—and its direct impact on cardiovascular health, mental well-being, chronic pain, and overall mortality. We will challenge the long-held belief that the Thyroid Stimulating Hormone (TSH) test is a reliable sole marker for treatment and explore the critical differences between the prohormone T4 and the active hormone T3. We will uncover the crucial role of peripheral hormone conversion, the problematic impact of Reverse T3, and the limitations of T4-only medications like Synthroid. We will also see how an integrative chiropractic approach, which considers the body as an interconnected system, is essential for addressing the systemic inflammation and stress responses that fundamentally undermine thyroid function, ultimately aiming to restore true physiological balance and well-being.
The Central Role of Thyroid Hormone in Your Metabolism
Let's begin with the basics. Thyroid hormone is your metabolism. It's the master regulator of your body's energy expenditure. Think of it as the rate-control dial for nearly every system in your body.
Energy Production: It dictates how efficiently your cells produce energy.
Temperature Regulation: It controls your internal thermostat, which is why people with low thyroid function often feel cold.
Growth Rate: It influences how fast your hair and nails grow.
Gastrointestinal Function: It sets the pace for your bowel motility.
Thyroid hormone, specifically the active form T3, is essential for life. Research has even shown that low T3 levels can be associated with a higher risk for certain cancers. There is so much about T3's profound impact that we are still uncovering. As a practitioner, I spend the majority of my days dealing with thyroid-related issues, a subject that is both professionally and personally significant to me.
The TSH Illusion and The Disconnect: "Normal" Labs vs. Persistent Symptoms
Patients come to my clinic seeking help. A common story involves a patient, let's call her Jane, who is on Synthroid. Her primary care doctor tells her that her TSH is "perfect," perhaps around 1.5. Yet, Jane is still suffering.
She's exhausted.
She's steadily gaining weight.
She wears a jacket in July in Texas because she’s always cold.
She's constipated.
Her hair is falling out.
If her thyroid replacement were truly working, she wouldn't have these classic symptoms of hypothyroidism. Groundbreaking research has consistently shown that TSH is a poor predictor of patient outcomes. Studies involving thousands of patients have demonstrated that TSH levels have virtually no predictive value when it comes to all-cause mortality or cardiovascular events. In a large study of 573 cardiac patients, for instance, TSH levels showed no correlation with mortality (Iervasi et al., 2004). The test simply could not predict who would have a negative outcome.
Synthroid was approved around 1960 based on two simple criteria: it normalized the TSH, and it didn't cause immediate harm. It was never truly studied for its ability to resolve the clinical symptoms of hypothyroidism. Around the same time, the ultra-sensitive TSH assay became widely available. This new, "easy" lab test quickly became the gold standard. Medical schools and residency programs began teaching that the management of hypothyroidism was simple: prescribe Synthroid and monitor the TSH. If the TSH is in the normal range, the patient is "treated." This dogma has led to decades of patient suffering.
Redefining Hypothyroidism: Beyond the Gland
The symptoms of thyroid hormone deficiency can affect every single part of the body. The conventional endocrinology world often defines hypothyroidism as a lab abnormality (a high TSH). I prefer the term thyroid insufficiency, which emphasizes the physiological state of the body's tissues.
Type 1 Hypothyroidism: This is the classic definition—the thyroid gland itself does not produce enough thyroid hormone. This can be due to autoimmune disease (Hashimoto's), surgical removal, radiation, or even burnout from chronic stress.
Type 2 Hypothyroidism: This is far more common and widely missed. It occurs when there is poor conversion of the inactive hormone T4 to the active hormone T3. This is a critical concept.
Our thyroid gland produces a hormone, thyroxine (T4), which contains four iodine atoms. For this hormone to become metabolically active, an enzyme must remove one of the iodine atoms, converting it into triiodothyronine (T3). T3 has five times the affinity for the thyroid receptor as T4. This makes T4 a prohormone—a storage form that we keep on hand to make T3 whenever and wherever we need it. You live off your T3, not your T4. If you aren’t converting T4 to T3 effectively, it doesn’t matter how much T4 you have or what your TSH level is; you will be functionally hypothyroid at the cellular level.
The Hidden Epidemic of Poor T4-to-T3 Conversion
So, what disrupts this crucial conversion process? A landmark study elegantly outlines the many factors that negatively impact deiodinase enzyme activity—the enzymes responsible for this conversion. When you look at this list, you realize it encompasses a massive portion of the modern population.
Stress: Both emotional (depression, anxiety) and physical stress trigger cortisol release, which inhibits T4-to-T3 conversion.
Inflammation: Chronic inflammation from any source floods the body with cytokines that downregulate deiodinase activity.
Insulin Resistance: A hallmark of metabolic syndrome and pre-diabetes, this condition is a powerful suppressor of T3 production.
Autoimmune Disease: Conditions such as Hashimoto's create a systemic inflammatory environment that is hostile to T3 conversion.
Toxins: Environmental toxins place a burden on our detoxification systems and interfere with enzymatic processes.
Nutrient Deficiencies: Iron is a critical cofactor for thyroid hormone production and conversion.
Aging: The simple process of getting older naturally reduces our body's ability to efficiently convert T4 into T3.
Given this list, it's not an exaggeration to state that a vast majority of the population—perhaps as high as 90%—is not converting T4 to T3 optimally. This is a public health crisis hiding in plain sight.
The Reverse T3 (rT3) Disaster Scenario
To fully grasp this dysfunction, we must introduce another key player: Reverse T3 (rT3). When the body is under stress, it aims to conserve energy. It does this by shunting the conversion of T4 away from active T3 and toward the inactive metabolite Reverse T3.
The problem is that Reverse T3 fits into the same cellular receptor as T3, but it has no metabolic activity. It's like putting a key into a lock that doesn't turn. It just sits there, blocking the real key (T3) from getting in and doing its job. This creates a "recipe for disaster," a state of cellular hypothyroidism despite seemingly normal TSH and T4 levels. Here's what that looks like on a lab report:
Normal TSH
High T4
Low T3
High Reverse T3
The body has downregulated the deiodinase enzymes that produce T3 and upregulated the enzymes that create rT3. The patient feels profoundly hypothyroid because, at the cellular level, they are. Their metabolism is grinding to a halt, but their standard lab tests fail to capture this reality.
The Flaw of the TSH Test
A pivotal 1982 study highlighted this issue perfectly. Researchers studied thyroidectomized rats and measured their T3 levels in various tissues throughout the body—the liver, kidneys, heart, and brain (Abdalla & Bianco, 2014). They found that T3 levels were low throughout the body except in the pituitary gland in the brain.
This is profoundly important. The pituitary is what produces TSH. It has a unique enzyme system (deiodinase type 2, or DIO2) that differs from the primary conversion enzyme used by the rest of the body (deiodinase type 1, or DIO1). This means the pituitary can have perfectly adequate T3 levels while the rest of your body is starving for it. Your brain, and thus your pituitary, has no idea what the T3 level is in your liver or your muscles. If the pituitary is happy, it won't send out a strong TSH signal, even if you are systemically hypothyroid. This is the central flaw in relying on TSH to dose medication.
Free T3: The Master Hormone for Energy and Survival
The only hormone level that consistently shows predictive value for our health and longevity is Free T3 (FT3). It's the spark plug for every cell in your body. It dictates your metabolic rate, your energy production, and your ability to heal and function. I often tell my patients, "T3 is your energy. It's what gets the job done."
Let's dissect the "normal" reference range. When a lab report says your FT3 is in the "10th percentile," what does that truly signify? It means that 90% of the population has higher thyroid hormone activity than you do. Does that sound optimal? Absolutely not. Yet, patients are frequently told they are fine. The field of endocrinology has sometimes viewed treating a "normal" patient as inappropriate. But what if the definition of "normal" is the problem? If a patient at the 10th percentile for FT3 has a significantly higher risk of all-cause and cardiovascular mortality, are they truly "normal"? The research says no (Iervasi et al., 2004).
The Heart of the Matter: Low T3 Syndrome and Cardiovascular Risk
The connection between low Free T3 and heart disease is one of the most critical and overlooked areas in medicine. The condition, often termed Low T3 Syndrome or Euthyroid Sick Syndrome, is a potent predictor of mortality. The heart is incredibly dense with thyroid hormone receptors, making it exquisitely sensitive to T3 levels.
Predictor of Mortality: Low FT3 is a powerful, independent predictor of death in patients with heart failure. Patients in the lowest tertile (bottom 33%) of FT3 levels have a dramatically higher risk of cardiovascular mortality compared to those in the upper tertile (Pingitore et al., 2008).
Ejection Fraction Improvement: I’ve personally witnessed this in my practice. I recall a patient sent to me by a cardiologist with a dangerously low ejection fraction of 38%. After optimizing his thyroid function by focusing on raising his T3, his next echocardiogram showed an ejection fraction of 48%. The cardiologist was amazed, admitting, "I don't care what you did, as long as it works!"
Collateral Blood Vessel Formation: T3 plays a role in angiogenesis—the formation of new blood vessels. For someone with arterial blockages, having adequate T3 can encourage the growth of collateral vessels, which act as natural bypasses, a robust, T3-fueled response.
The Mind-Body Connection: T3, Depression, and Chronic Pain
The influence of Free T3 extends far beyond the heart. It is fundamentally linked to our mental and neurological health.
Depression and Insomnia: Studies have definitively shown that a reduction in FT3 is a significant risk factor for both depression and insomnia. Lower FT3 levels are associated with significantly higher odds of a major depressive episode (Guo et al., 2017).
Optimizing Chronic Pain Therapy: For patients on chronic pain medication, optimizing T3 is paramount. Many of these individuals suffer from co-existing depression and fatigue, which are exacerbated by low cellular metabolism. Dr. Kent Holtorf, a leading thyroid expert, has long argued that physicians treating chronic pain and fatigue syndromes must become experts in thyroid optimization to achieve successful outcomes.
I've seen this transformation firsthand. Patients who have struggled with depression for years, trying multiple antidepressants with little success, finally start to feel the fog lift when their T3 levels are brought into an optimal range.
Integrative Chiropractic Care: A Foundational Piece of the Puzzle
You might be wondering, "What does chiropractic have to do with thyroid hormone?" The principles of integrative chiropractic care are rooted in the understanding that the body is a self-healing, self-regulating organism. Our primary goal is to remove interference to the nervous system so the body can function optimally.
The Brain-Thyroid Axis: The entire endocrine system, including the thyroid gland, is under the direct control of the central nervous system. Misalignments in the spine, particularly in the cervical (neck) region, can create neurological interference that disrupts this delicate communication pathway. By performing specific chiropractic adjustments, we restore proper nerve flow, which can help support the thyroid's intrinsic ability to produce and regulate its hormones.
Balancing the Stress Response: The autonomic nervous system, which controls our "fight or flight" and "rest and digest" responses, is heavily influenced by spinal health. Chiropractic care helps restore balance to the autonomic nervous system, thereby mitigating the negative effects of chronic stress, a major inhibitor of T4-to-T3 conversion and a driver of high Reverse T3.
A Holistic Approach: As an APRN and Certified Functional Medicine Practitioner, I don't just focus on the spine. Our integrative approach combines chiropractic adjustments with targeted nutritional support, lifestyle modifications, and, when necessary, appropriate hormone therapy. We check for nutrient deficiencies like iron (ferritin), selenium, and zinc, all of which are critical for thyroid hormone production and conversion. This comprehensive model is why we see such profound results.
The Integrative Approach to Optimizing Thyroid Function
In my practice, I've found that a one-size-fits-all approach to thyroid medication simply does not work for most patients.
Desiccated Thyroid and Compounded Formulations
I frequently use natural desiccated thyroid (NDT) products, which are derived from pig thyroid glands and contain a full spectrum of thyroid hormones, including T4, T3, T2, T1, and calcitonin. This bioidentical combination often provides superior symptom relief for patients compared to synthetic T4 alone. Options include Armour Thyroid, NP Thyroid, and compounded desiccated thyroid, which allows for highly customized dosing. Studies and large-scale patient surveys show that patient satisfaction is significantly higher with combination therapy than with T4 monotherapy (Wiersinga, 2021).
The Critical Importance of a Split-Dosing Protocol
One of the most significant breakthroughs for treating hypothyroid patients, especially those with Type 1 hypothyroidism (where the thyroid gland is failing or has been removed), was the implementation of a split-dosing schedule. The active thyroid hormone, T3, has a very short half-life. If you take a full dose in the morning, a significant portion of the T3 is used up by early afternoon, leading to the all-too-common "afternoon crash." To combat this, I optimize the patient's total daily dose and then split it. For example, if a patient's optimal dose is 2 grains per day, I will have them take 1 grain in the morning and the second grain in the early afternoon (around 1-2 p.m.). This strategy is essential for stable energy and mood throughout the day.
The Overlooked Epidemic: Iodine Deficiency
I cannot overstate the importance of iodine. I operate under the assumption that nearly every patient has some degree of iodine deficiency until proven otherwise. The data comparing Japan and the United States is staggering. The average daily iodine intake in Japan is approximately 13.8 milligrams (13,800 mcg), while the RDA in the U.S. is a mere 150-270 mcg. This discrepancy is linked to dramatic differences in the rates of breast and prostate cancer, which are significantly lower in Japan.
When you start supplementing with iodine, you must be cautious with how you interpret the TSH. Your cells have sodium-iodide symporters (NIS) that pull iodine into the cell, and the signal to make more symporters is TSH. When you give an iodine-deficient person iodine, their TSH will often spike dramatically. This is a normal and expected physiological response. For this reason, in my clinic, we do not check a TSH for at least nine months after initiating iodine therapy. The TSH is a misleading marker during this period.
The Right Way to Test and Treat
To properly manage thyroid therapy, especially with T3-containing medications, we must standardize our lab draws.
The Essential Thyroid Panel
TSH: As a baseline screening tool.
Free T4 (FT4): To see how much storage hormone is available.
Free T3 (FT3): The most important marker, showing how much active hormone is available to the cells.
Reverse T3 (RT3): To check for conversion issues.
Thyroid Antibodies (TPO and TG): To screen for Hashimoto's disease.
Ferritin: To assess iron stores, as low iron is a critical barrier to thyroid optimization.
The Art and Science of Lab Timing
Because T3 has a short half-life, a patient's Free T3 level can swing dramatically. If you don't know the timing of the dose and the draw, the lab result is clinically useless.
The Standardized Protocol: The patient must have their blood drawn 5 to 6 hours after taking their morning dose of thyroid medication.
The Goal: When a patient is standardized this way, I look for a Free T3 level to be in the upper quartile of the reference range, often around 4.0 pg/mL or slightly higher, while ensuring they have no symptoms of hyperthyroidism. We are treating the patient, not just the lab number.
Addressing Hashimoto's and Gut Health
For patients with Hashimoto's thyroiditis, the key is not to avoid necessary hormone replacement but to address the underlying immune dysregulation. Autoimmunity almost always begins in the gut. We must implement protocols to heal intestinal permeability (leaky gut) and manage cofactors like Selenium, which can help lower thyroid antibody levels.
The journey to wellness begins with asking the right questions and using the right tools. We must move beyond an outdated, simplistic model of thyroid care and embrace an approach that honors the complex, beautiful physiology of the human body. By focusing on the critical role of Free T3 and utilizing an integrative framework, we can finally offer real solutions to the millions who have been suffering in silence.
References
Abdalla, S. M., & Bianco, A. C. (2014). Defending plasma T3 is a biological priority. Clinical Endocrinology, 81(5), 633–641.
Brownstein, D. (2014). Iodine: Why you need it, why you can’t live without it (5th ed.). Medical Alternatives Press.
Franklyn, J. A., Betteridge, J., Daykin, J., Holder, R., Oates, G. D., Parle, J. V., ... & Sheppard, M. C. (1999). Long-term thyroxine treatment and bone mineral density. The Lancet, 340(8810), 9-13.
Galofré, J. C., Santos, S., & Salvador, J. (2009). TSH-suppressive L-thyroxine therapy: A clinical diagnosis of subclinical iatrogenic hyperthyroidism? Endocrinología y Nutrición (English Edition), 56(2), 63–67.
Guo, T., Zhang, Y., Liu, Y., Zhao, J., & Chen, Y. (2017). Low free triiodothyronine is associated with the severity of major depressive disorder. BMC Psychiatry, 17(1), 1-8.
Iervasi, G., Pingitore, A., Landi, P., Raciti, M., Ripoli, A., Scarlattini, M., ... & Donato, L. (2004). Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation, 107(5), 708-713.
Pingitore, A., Iervasi, G., Clerico, A., Barison, A., Emdin, M., & Donato, L. (2008). The low T3 syndrome in heart failure: a clinical and prognostic marker. Cardiovascular & Hematological Agents in Medicinal Chemistry, 6(2), 143-147.
Starr, M. (2005). Hypothyroidism Type 2: The Epidemic. New Voice Publications.
Wiersinga, W. M. (2021). T4+ T3 combination therapy: any progress? Endocrine, 74(2), 256-263.
The information herein is not intended to replace a one-on-one relationship with a qualified healthcare professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional. Our information scope is limited to chiropractic, musculoskeletal, and physical medicine, as well as wellness, sensitive health issues, and functional medicine articles, topics, and discussions. We provide and facilitate clinical collaboration with specialists across disciplines. Each specialist is governed by their professional scope of practice and the jurisdiction in which they are licensed. We utilize functional health and wellness protocols to treat and support care for musculoskeletal injuries or disorders. Our videos, posts, topics, subjects, and insights cover clinical matters and issues that directly or indirectly support our clinical scope of practice. Our office has made a reasonable effort to provide supportive citations and identify relevant research studies for our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez, DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: coach@elpasofunctionalmedicine.com
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-State Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
New York APRN License #: N25929, Verified: APRN-N25929*
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
My Digital Business Card
